Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Microprocessor-controlled prosthetic knees for limited community ambulators with above-knee amputation.

Official title: Fall-related Health Outcome in Lower Limb Prosthesis Users: A Pragmatic Clinical Trial to Assess Effectiveness of Microprocessor-controlled Prosthetic Knees

Run by Hanger Institute for Clinical Research and Education, LLC · NCT06937242 · Data updated 2026-11-12

This test will see if switching to a microprocessor-controlled prosthetic knee reduces fall-related health problems and improves walking speed, mobility, and quality of life for adults with above-knee amputations who are limited community ambulators compared with non-microprocessor knees.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorHanger Institute for Clinical Research and Education, LLC
Industry-sponsored
Locations1 site (Austin, Texas)
StatusRecruiting
StartedJuly 11, 2025
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT06937242 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a unilateral transfemoral or knee-disarticulation amputation at least 6 months prior who currently use a non-microprocessor prosthetic knee, received a replacement non-microprocessor knee 4–24 months ago, meet K2 (limited community ambulator) criteria, and can read and understand English are ideal candidates.

Probably not a fit

People who are high-functioning ambulators (K3/K4), have medical conditions that prevent safe participation, weigh 275 pounds or more, or have bilateral above-knee amputations are unlikely to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 12-month pragmatic randomized controlled trial enrolling unilateral transfemoral or knee-disarticulation prosthesis users classified as limited community ambulators (Medicare K2). Eligible participants who recently received a non-microprocessor knee as part of routine care will be randomized to continue their current non-microprocessor knee or receive a microprocessor-controlled knee (Ottobock C-Leg 4 or Kenevo). The trial will track fall-related health outcomes (including anxiety, self-efficacy, avoidance behaviors, and fall frequency) as well as mobility measures, walking speed, and health-related quality of life. Participants are recruited through routine prosthetic care with scheduled fittings and follow-up visits at participating clinics.

Why it matters

Potential benefit: If successful, the intervention could reduce falls and fall-related health burdens while improving mobility, walking speed, and quality of life for K2 prosthesis users.

How similar studies have gone: Prior research has shown benefits of microprocessor knees in higher-functioning (K3+) users, but evidence in K2 limited community ambulators is limited, making this a relatively novel application for that group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Unilateral transfemoral or knee disarticulation limb loss.
* 6 months or longer since time of limb loss.
* Current user of a prosthesis with a non-microprocessor-controlled prosthetic knee.
* Received a replacement prosthesis with a non-microprocessor knee in the past 4-24 months.
* Clinician has deemed patient limited community ambulator (Medicare functional classification level K2).
* In addition, Medicare functional classification level K2 as determined by at least one of the following criteria:

  1. Houghton Score: 5-10
  2. Prosthetic Limb Users Survey of Mobility (PLUS-M) T-Score: if amputation etiology is vascular disease/diabetes \<49.45, otherwise, \<36.75.
  3. Amputee Mobility Predictor (AMPPRO) score: 27-42 collected within the last 24 months
* Ability to read, write, and understand English.

Exclusion Criteria:

* Any health condition that would prevent safely completing trial activities.
* Any individuals that weigh 275 lbs or more.
* Any individuals who wear their prosthesis less than 3 days a week or less than a total of 24 hours a week
* Individuals with a history of acute or chronic residual limb breakdown
* Individuals with declining health status such that he/she subsequently reports reduced activity over the past 6 months

Where it's running

  • Hanger Inc.
    Austin, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Shane R. Wurdeman, PhD — Hanger Institute for Clinical Research and Education
  • Study coordinator: Shane R. Wurdeman, PhD
  • Email: swurdeman@hanger.com
  • Phone: 281-829-4746

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.